SIMILAR PATTERNS OF AMINO ACIDS FOR 6AY4_A_TPFA506
List of similar pattern of amino acids derived from ASSAM searchHit | Macromolecule/ Organism |
Pfam | Res. | Interface | HETATM | RMSD | Dali Z-score | Seq. Identity (%) | View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1gzc | ERYTHRINACRISTA-GALLI LECTIN (Erythrinacrista-galli) |
PF00139(Lectin_legB) | 5 | TYR A 172PHE A 93ALA A 125THR A 123LEU A 204 | None | 1.48A | 6ay4A-1gzcA:undetectable | 6ay4A-1gzcA:19.87 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1r4p | SHIGA-LIKE TOXINTYPE II A SUBUNIT (Escherichiacoli) |
PF00161(RIP) | 5 | TYR A 90MET A 108ALA A 79PHE A 92LEU A 142 | NoneNoneNoneFMT A3015 ( 4.9A)None | 1.35A | 6ay4A-1r4pA:undetectable | 6ay4A-1r4pA:19.25 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1rrv | GLYCOSYLTRANSFERASEGTFD (Amycolatopsisorientalis) |
PF03033(Glyco_transf_28) | 5 | TYR A 188ALA A 159PHE A 162ALA A 163LEU A 170 | TYR A 188 ( 1.3A)ALA A 159 ( 0.0A)PHE A 162 ( 1.3A)ALA A 163 ( 0.0A)LEU A 170 ( 0.6A) | 1.26A | 6ay4A-1rrvA:undetectable | 6ay4A-1rrvA:22.85 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1uuo | DIHYDROOROTATEDEHYDROGENASE (Rattus rattus) |
PF01180(DHO_dh) | 5 | MET A 43ALA A 55ALA A 59THR A 63LEU A 111 | BRF A1397 (-4.1A)BRF A1397 (-3.2A)BRF A1397 (-3.5A)BRF A1397 ( 4.7A)None | 1.08A | 6ay4A-1uuoA:undetectable | 6ay4A-1uuoA:20.87 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1wc8 | TRAFFICKING PROTEINPARTICLE COMPLEXSUBUNIT3 (Mus musculus) |
PF04051(TRAPP) | 5 | MET A 165PHE A 103ALA A 75ALA A 79LEU A 107 | None | 1.32A | 6ay4A-1wc8A:undetectable | 6ay4A-1wc8A:17.56 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1x8v | CYTOCHROME P450 51 (Mycobacteriumtuberculosis) |
PF00067(p450) | 7 | MET A 79PHE A 83PHE A 255ALA A 256THR A 260LEU A 321CYH A 394 | ESL A 471 ( 4.4A)NoneNoneESL A 471 ( 3.4A)HEM A 470 (-3.6A)HEM A 470 (-4.1A)HEM A 470 (-2.4A) | 1.03A | 6ay4A-1x8vA:41.4 | 6ay4A-1x8vA:32.43 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1x8v | CYTOCHROME P450 51 (Mycobacteriumtuberculosis) |
PF00067(p450) | 7 | TYR A 76MET A 79PHE A 83PHE A 255THR A 260LEU A 321CYH A 394 | ESL A 471 ( 3.8A)ESL A 471 ( 4.4A)NoneNoneHEM A 470 (-3.6A)HEM A 470 (-4.1A)HEM A 470 (-2.4A) | 0.90A | 6ay4A-1x8vA:41.4 | 6ay4A-1x8vA:32.43 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1x8v | CYTOCHROME P450 51 (Mycobacteriumtuberculosis) |
PF00067(p450) | 5 | TYR A 76PHE A 255ALA A 256THR A 260CYH A 394 | ESL A 471 ( 3.8A)NoneESL A 471 ( 3.4A)HEM A 470 (-3.6A)HEM A 470 (-2.4A) | 1.15A | 6ay4A-1x8vA:41.4 | 6ay4A-1x8vA:32.43 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1zlj | DORMANCY SURVIVALREGULATOR (Mycobacteriumtuberculosis) |
PF00196(GerE) | 5 | MET A 194ALA A 201PHE A 203ALA A 204LEU A 150 | None | 1.40A | 6ay4A-1zljA:undetectable | 6ay4A-1zljA:11.32 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2afb | 2-KETO-3-DEOXYGLUCONATE KINASE (Thermotogamaritima) |
PF00294(PfkB) | 5 | TYR A 31PHE A 317ALA A 40THR A 53LEU A 55 | None | 1.13A | 6ay4A-2afbA:undetectable | 6ay4A-2afbA:20.73 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2fe8 | REPLICASEPOLYPROTEIN 1AB (Severe acuterespiratorysyndrome-relatedcoronavirus) |
PF08715(Viral_protease) | 5 | TYR A 72PHE A 80TYR A 73ALA A 154ALA A 150 | None | 1.47A | 6ay4A-2fe8A:undetectable | 6ay4A-2fe8A:21.56 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2q22 | UNCHARACTERIZEDPROTEIN (Trichormusvariabilis) |
PF08854(DUF1824) | 5 | PHE A 137TYR A 71ALA A 74LEU A 18CYH A 117 | None | 1.35A | 6ay4A-2q22A:undetectable | 6ay4A-2q22A:14.42 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2w55 | XANTHINEDEHYDROGENASE (Rhodobactercapsulatus) |
PF01315(Ald_Xan_dh_C)PF02738(Ald_Xan_dh_C2) | 5 | PHE B 376TYR B 319ALA B 373ALA B 369LEU B 741 | None | 1.27A | 6ay4A-2w55B:undetectable | 6ay4A-2w55B:20.30 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2xsr | CATECHOL 1,2DIOXYGENASE (Acinetobacterradioresistens) |
PF00775(Dioxygenase_C)PF04444(Dioxygenase_N) | 5 | TYR A 243ALA A 251PHE A 250ALA A 249CYH A 197 | None | 1.48A | 6ay4A-2xsrA:undetectable | 6ay4A-2xsrA:22.67 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3f40 | UNCHARACTERIZEDNTF2-LIKE PROTEIN (Cytophagahutchinsonii) |
PF12680(SnoaL_2) | 5 | TYR A 60ALA A 86PHE A 105LEU A 101CYH A 73 | None | 1.24A | 6ay4A-3f40A:undetectable | 6ay4A-3f40A:13.70 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3f40 | UNCHARACTERIZEDNTF2-LIKE PROTEIN (Cytophagahutchinsonii) |
PF12680(SnoaL_2) | 5 | TYR A 60MET A 80ALA A 86PHE A 105LEU A 101 | None | 1.48A | 6ay4A-3f40A:undetectable | 6ay4A-3f40A:13.70 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ksw | STEROL 14-ALPHADEMETHYLASE (Trypanosomacruzi) |
PF00067(p450) | 6 | TYR A 103MET A 106ALA A 287ALA A 291LEU A 356CYH A 422 | NoneVNF A 490 ( 3.8A)VNF A 490 ( 3.9A)VNF A 490 ( 4.0A)NoneHEM A 488 (-2.2A) | 0.91A | 6ay4A-3kswA:38.5 | 6ay4A-3kswA:36.65 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ksw | STEROL 14-ALPHADEMETHYLASE (Trypanosomacruzi) |
PF00067(p450) | 8 | TYR A 103MET A 106PHE A 110ALA A 287PHE A 290ALA A 291THR A 295CYH A 422 | NoneVNF A 490 ( 3.8A)NoneVNF A 490 ( 3.9A)NoneVNF A 490 ( 4.0A)VNF A 490 ( 4.0A)HEM A 488 (-2.2A) | 0.95A | 6ay4A-3kswA:38.5 | 6ay4A-3kswA:36.65 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ksw | STEROL 14-ALPHADEMETHYLASE (Trypanosomacruzi) |
PF00067(p450) | 5 | TYR A 103MET A 106PHE A 110TYR A 116CYH A 422 | NoneVNF A 490 ( 3.8A)NoneVNF A 490 (-4.6A)HEM A 488 (-2.2A) | 1.01A | 6ay4A-3kswA:38.5 | 6ay4A-3kswA:36.65 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3l4d | STEROL 14-ALPHADEMETHYLASE (Leishmaniainfantum) |
PF00067(p450) | 9 | MET A 105PHE A 109TYR A 115ALA A 286PHE A 289ALA A 290THR A 294LEU A 355CYH A 422 | TPF A 490 ( 4.0A)TPF A 490 (-4.5A)HEM A 481 ( 4.9A)TPF A 490 (-3.4A)TPF A 490 (-4.3A)TPF A 490 ( 3.4A)TPF A 490 ( 3.5A)TPF A 490 (-4.4A)HEM A 481 (-2.2A) | 0.86A | 6ay4A-3l4dA:46.5 | 6ay4A-3l4dA:36.02 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3l4d | STEROL 14-ALPHADEMETHYLASE (Leishmaniainfantum) |
PF00067(p450) | 6 | MET A 105TYR A 102PHE A 289ALA A 290THR A 294CYH A 422 | TPF A 490 ( 4.0A)HEM A 481 (-4.7A)TPF A 490 (-4.3A)TPF A 490 ( 3.4A)TPF A 490 ( 3.5A)HEM A 481 (-2.2A) | 1.26A | 6ay4A-3l4dA:46.5 | 6ay4A-3l4dA:36.02 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3l4d | STEROL 14-ALPHADEMETHYLASE (Leishmaniainfantum) |
PF00067(p450) | 9 | TYR A 102MET A 105PHE A 109TYR A 115ALA A 286PHE A 289THR A 294LEU A 355CYH A 422 | HEM A 481 (-4.7A)TPF A 490 ( 4.0A)TPF A 490 (-4.5A)HEM A 481 ( 4.9A)TPF A 490 (-3.4A)TPF A 490 (-4.3A)TPF A 490 ( 3.5A)TPF A 490 (-4.4A)HEM A 481 (-2.2A) | 0.85A | 6ay4A-3l4dA:46.5 | 6ay4A-3l4dA:36.02 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3pb0 | DIHYDRODIPICOLINATESYNTHASE (Thermotogamaritima) |
PF00701(DHDPS) | 5 | TYR A 118ALA A 152PHE A 184ALA A 148THR A 173 | None | 1.26A | 6ay4A-3pb0A:undetectable | 6ay4A-3pb0A:20.56 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3wiw | GLYCOSYL HYDROLASEFAMILY 88 (Pedobacterheparinus) |
PF07470(Glyco_hydro_88) | 5 | MET A 284PHE A 294ALA A 245ALA A 249LEU A 316 | None | 1.29A | 6ay4A-3wiwA:undetectable | 6ay4A-3wiwA:22.53 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4c3o | HYDROGENASE-1 LARGESUBUNIT (Salmonellaenterica) |
PF00374(NiFeSe_Hases) | 5 | TYR A 529ALA A 70ALA A 84THR A 82LEU A 515 | NoneNoneNoneNFU A1004 (-4.0A)NFU A1004 (-3.7A) | 1.45A | 6ay4A-4c3oA:undetectable | 6ay4A-4c3oA:21.47 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4cgy | DNA TOPOISOMERASE3-ALPHA (Homo sapiens) |
PF01131(Topoisom_bac)PF01751(Toprim) | 5 | MET A 84PHE A 73TYR A 75ALA A 50LEU A 193 | None | 1.50A | 6ay4A-4cgyA:undetectable | 6ay4A-4cgyA:19.82 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4g3j | STEROL14-ALPHA-DEMETHYLASE (Trypanosomabrucei) |
PF00067(p450) | 5 | MET A 106PHE A 110TYR A 103ALA A 115CYH A 422 | VNT A 502 ( 3.9A)VNT A 502 (-4.4A)VNT A 502 ( 4.8A)VNT A 502 ( 4.7A)HEM A 501 (-2.3A) | 1.45A | 6ay4A-4g3jA:46.2 | 6ay4A-4g3jA:36.32 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4g3j | STEROL14-ALPHA-DEMETHYLASE (Trypanosomabrucei) |
PF00067(p450) | 9 | MET A 106PHE A 110TYR A 103ALA A 287PHE A 290ALA A 291THR A 295LEU A 356CYH A 422 | VNT A 502 ( 3.9A)VNT A 502 (-4.4A)VNT A 502 ( 4.8A)VNT A 502 ( 3.9A)VNT A 502 (-4.4A)HEM A 501 ( 3.5A)VNT A 502 ( 3.2A)VNT A 502 ( 4.5A)HEM A 501 (-2.3A) | 0.95A | 6ay4A-4g3jA:46.2 | 6ay4A-4g3jA:36.32 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4g3j | STEROL14-ALPHA-DEMETHYLASE (Trypanosomabrucei) |
PF00067(p450) | 7 | PHE A 110TYR A 116ALA A 287ALA A 291THR A 295LEU A 356CYH A 422 | VNT A 502 (-4.4A)HEM A 501 ( 4.5A)VNT A 502 ( 3.9A)HEM A 501 ( 3.5A)VNT A 502 ( 3.2A)VNT A 502 ( 4.5A)HEM A 501 (-2.3A) | 0.92A | 6ay4A-4g3jA:46.2 | 6ay4A-4g3jA:36.32 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4g3j | STEROL14-ALPHA-DEMETHYLASE (Trypanosomabrucei) |
PF00067(p450) | 6 | TYR A 103MET A 106PHE A 290THR A 295LEU A 356CYH A 422 | VNT A 502 ( 4.8A)VNT A 502 ( 3.9A)VNT A 502 (-4.4A)VNT A 502 ( 3.2A)VNT A 502 ( 4.5A)HEM A 501 (-2.3A) | 1.10A | 6ay4A-4g3jA:46.2 | 6ay4A-4g3jA:36.32 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4g3j | STEROL14-ALPHA-DEMETHYLASE (Trypanosomabrucei) |
PF00067(p450) | 5 | TYR A 103TYR A 116THR A 295LEU A 356CYH A 422 | VNT A 502 ( 4.8A)HEM A 501 ( 4.5A)VNT A 502 ( 3.2A)VNT A 502 ( 4.5A)HEM A 501 (-2.3A) | 1.24A | 6ay4A-4g3jA:46.2 | 6ay4A-4g3jA:36.32 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4i5u | CHIMERIC CEL6A (Chaetomiumthermophilum;Humicolainsolens;Trichodermareesei) |
PF01341(Glyco_hydro_6) | 5 | PHE A 334ALA A 281PHE A 284ALA A 285LEU A 297 | None | 1.20A | 6ay4A-4i5uA:undetectable | 6ay4A-4i5uA:22.43 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4izd | ENOYL-COAHYDRATASE/ISOMERASEFAMILY PROTEIN (Ruegeriapomeroyi) |
PF00378(ECH_1) | 5 | MET A 159ALA A 125ALA A 121THR A 148LEU A 139 | None | 1.42A | 6ay4A-4izdA:undetectable | 6ay4A-4izdA:21.22 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4uhi | STEROL 14-ALPHADEMETHYLASE (Homo sapiens) |
PF00067(p450) | 6 | TYR A 131PHE A 139TYR A 145ALA A 311THR A 315CYH A 449 | VFV A 580 (-4.1A)VFV A 580 (-4.2A)HEM A 540 (-4.5A)HEM A 540 ( 3.4A)HEM A 540 (-3.6A)HEM A 540 (-2.3A) | 0.67A | 6ay4A-4uhiA:48.1 | 6ay4A-4uhiA:39.74 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4uym | 14-ALPHA STEROLDEMETHYLASE (Aspergillusfumigatus) |
PF00067(p450) | 6 | TYR A 122PHE A 130TYR A 136ALA A 303ALA A 307CYH A 463 | VOR A 590 (-3.8A)VOR A 590 (-4.6A)HEM A 580 (-4.6A)VOR A 590 ( 4.4A)VOR A 590 ( 4.0A)HEM A 580 (-2.3A) | 0.80A | 6ay4A-4uymA:43.8 | 6ay4A-4uymA:35.33 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4xri | PUTATIVEUNCHARACTERIZEDPROTEIN (Chaetomiumthermophilum) |
PF03810(IBN_N)PF13513(HEAT_EZ) | 5 | MET A 604ALA A 645PHE A 646ALA A 647LEU A 677 | NoneGOL A 915 ( 4.5A)NoneNoneNone | 1.40A | 6ay4A-4xriA:undetectable | 6ay4A-4xriA:18.39 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4ysw | XANTHINEDEHYDROGENASE/OXIDASE (Rattusnorvegicus) |
PF00111(Fer2)PF00941(FAD_binding_5)PF01315(Ald_Xan_dh_C)PF01799(Fer2_2)PF02738(Ald_Xan_dh_C2)PF03450(CO_deh_flav_C) | 5 | MET A 779ALA A 811ALA A 815THR A 819CYH A 633 | None | 1.23A | 6ay4A-4yswA:undetectable | 6ay4A-4yswA:17.84 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5fsa | CYP51 VARIANT1 (Candidaalbicans) |
PF00067(p450) | 5 | TYR A 118PHE A 126PHE A 228THR A 311LEU A 376 | X2N A 590 ( 4.0A)X2N A 590 (-4.8A)X2N A 590 (-4.9A)HEM A 580 (-3.6A)X2N A 590 (-4.3A) | 1.40A | 6ay4A-5fsaA:40.6 | 6ay4A-5fsaA:36.91 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5fsa | CYP51 VARIANT1 (Candidaalbicans) |
PF00067(p450) | 5 | TYR A 118PHE A 126THR A 311LEU A 376CYH A 470 | X2N A 590 ( 4.0A)X2N A 590 (-4.8A)HEM A 580 (-3.6A)X2N A 590 (-4.3A)HEM A 580 (-2.2A) | 0.86A | 6ay4A-5fsaA:40.6 | 6ay4A-5fsaA:36.91 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5fsa | CYP51 VARIANT1 (Candidaalbicans) |
PF00067(p450) | 5 | TYR A 118TYR A 132PHE A 228THR A 311LEU A 376 | X2N A 590 ( 4.0A)HEM A 580 (-4.1A)X2N A 590 (-4.9A)HEM A 580 (-3.6A)X2N A 590 (-4.3A) | 1.23A | 6ay4A-5fsaA:40.6 | 6ay4A-5fsaA:36.91 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5fsa | CYP51 VARIANT1 (Candidaalbicans) |
PF00067(p450) | 5 | TYR A 118TYR A 132THR A 311LEU A 376CYH A 470 | X2N A 590 ( 4.0A)HEM A 580 (-4.1A)HEM A 580 (-3.6A)X2N A 590 (-4.3A)HEM A 580 (-2.2A) | 0.66A | 6ay4A-5fsaA:40.6 | 6ay4A-5fsaA:36.91 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5hs1 | LANOSTEROL 14-ALPHADEMETHYLASE (Saccharomycescerevisiae) |
PF00067(p450) | 6 | TYR A 126PHE A 134TYR A 140PHE A 236THR A 318LEU A 380 | VOR A 602 ( 3.8A)VOR A 602 (-4.7A)HEM A 601 (-4.3A)VOR A 602 (-4.4A)HEM A 601 (-3.4A)VOR A 602 (-4.0A) | 1.37A | 6ay4A-5hs1A:42.8 | 6ay4A-5hs1A:32.59 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5hs1 | LANOSTEROL 14-ALPHADEMETHYLASE (Saccharomycescerevisiae) |
PF00067(p450) | 6 | TYR A 126PHE A 134TYR A 140THR A 318LEU A 380CYH A 470 | VOR A 602 ( 3.8A)VOR A 602 (-4.7A)HEM A 601 (-4.3A)HEM A 601 (-3.4A)VOR A 602 (-4.0A)HEM A 601 (-2.4A) | 0.71A | 6ay4A-5hs1A:42.8 | 6ay4A-5hs1A:32.59 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5jlc | LANOSTEROL 14-ALPHADEMETHYLASE ([Candida]glabrata) |
PF00067(p450) | 5 | TYR A 127PHE A 135TYR A 141PHE A 237LEU A 381 | 1YN A 602 ( 3.8A)1YN A 602 ( 4.6A)HEM A 601 (-4.2A)1YN A 602 (-4.5A)1YN A 602 ( 4.7A) | 1.31A | 6ay4A-5jlcA:42.3 | 6ay4A-5jlcA:32.26 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5jlc | LANOSTEROL 14-ALPHADEMETHYLASE ([Candida]glabrata) |
PF00067(p450) | 6 | TYR A 127PHE A 135TYR A 141THR A 319LEU A 381CYH A 472 | 1YN A 602 ( 3.8A)1YN A 602 ( 4.6A)HEM A 601 (-4.2A)HEM A 601 ( 3.5A)1YN A 602 ( 4.7A)HEM A 601 (-2.3A) | 0.62A | 6ay4A-5jlcA:42.3 | 6ay4A-5jlcA:32.26 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5kol | UNCHARACTERIZEDPROTEIN (Escherichiacoli) |
PF02464(CinA) | 5 | MET A 146PHE A 148ALA A 159PHE A 162ALA A 163 | None | 1.46A | 6ay4A-5kolA:undetectable | 6ay4A-5kolA:17.19 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5kvk | PROTEIN KP700603 (Klebsiellapneumoniae) |
PF02464(CinA) | 5 | MET A 141PHE A 143ALA A 154PHE A 157ALA A 158 | None | 1.32A | 6ay4A-5kvkA:undetectable | 6ay4A-5kvkA:14.10 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5lgx | PENTAERYTHRITOLTETRANITRATEREDUCTASE (Enterobactercloacae) |
PF00724(Oxidored_FMN) | 5 | TYR A 267PHE A 293ALA A 261LEU A 180CYH A 222 | None | 1.38A | 6ay4A-5lgxA:undetectable | 6ay4A-5lgxA:21.89 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5mrw | POTASSIUM-TRANSPORTING ATPASE KDPCSUBUNITPOTASSIUM-TRANSPORTING ATPASEPOTASSIUM-BINDINGSUBUNIT (Escherichiacoli) |
PF02669(KdpC)PF03814(KdpA) | 5 | TYR A 62MET A 57ALA C 7THR C 10LEU A 170 | None | 1.20A | 6ay4A-5mrwA:undetectable | 6ay4A-5mrwA:22.52 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5uwa | PROBABLEPHOSPHOLIPID-BINDINGPROTEIN MLAC (Escherichiacoli) |
PF05494(MlaC) | 5 | MET A 166PHE A 150ALA A 35THR A 38LEU A 109 | 8ND A 301 ( 3.9A)8ND A 301 (-4.0A)8ND A 301 ( 4.2A)8ND A 301 ( 4.8A)None | 1.40A | 6ay4A-5uwaA:2.0 | 6ay4A-5uwaA:18.46 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5wbg | CYTOCHROME P450 2B6 (Homo sapiens) |
no annotation | 5 | PHE A 297ALA A 298THR A 302LEU A 363CYH A 436 | 9ZJ A 502 ( 4.5A)9ZJ A 502 ( 3.5A)9ZJ A 502 ( 3.9A)HEM A 501 (-4.3A)HEM A 501 (-2.0A) | 0.76A | 6ay4A-5wbgA:31.7 | 6ay4A-5wbgA:14.25 |